newbie question re genomic/biomarker testing
I had a recent MRI which showed two lesions, one with a PI-RAD score of 5, the other with score of 3. So, highly likely to be cancerous.
I've been dealing with another, rare form of cancer (GIST) for two and a half years; it's incurable but treatable, for an unknown length of time. For that cancer, mutational/biomarker testing is necessary as different mutations respond to different medications. In a weird way, it's almost good to have a different form of cancer as I'm not nearly as freaked out about prostate cancer having already gone through a different kind of cancer.
It appears (at least from the reading I've done thus far) that mutational or genomic testing isn't as widespread for prostate cancer. I will be getting treatment at Memorial Sloan Kettering (where I get treatment for my other cancer) and I assume they routinely do this type of testing. But I've also heard of other tests, e.g., Prolaris, Decipher, etc. and am wondering how important people think this kind of genomic/biomarker testing is for prostate cancer. Also wondering is anyone knows if those tests provide more information than the MSK-IMPACT test does. Knowning what I know from the cancer I have, I do believe that the more information one has about their cancer, the better.
Thanks in advance for any help!
Comments
-
I would leave that question to the very knowledgeable people at MSK. It's also a bit premature because you haven't been diagnosed with prostate cancer as yet. I am reasonably sure that a biopsy is in your near future with special attention to the PI-RADS 5 lesion.
I hope they won't find anything worrisome…
0 -
Hi,
As Old salt said you will need a biopsy to grade your Prostate cancer which can determine your treatment path. I feel the Gleason score should tell you what comes next. If you do have Prostate cancer I would get a PMSA PET scan which is very sensitive at picking up metatastic spread.
Dave 3+4
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.9K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 794 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 540 Sarcoma
- 733 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards